STELIOS PAPADOPOULOS, a director at $EXEL, sold 100,000 shares of the company on 11-12-2025 for an estimated $4,355,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.8% of their shares of this class of stock. Following this trade, they now own 1,189,228 shares of this class of $EXEL stock.
$EXEL Insider Trading Activity
$EXEL insiders have traded $EXEL stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $EXEL stock by insiders over the last 6 months:
- CHRISTOPHER J. SENNER (EVP and CFO) sold 100,000 shares for an estimated $4,600,000
- STELIOS PAPADOPOULOS sold 100,000 shares for an estimated $4,355,000
- AMY C. PETERSON (EVP Prod Dev & Med Aff & CMO) sold 72,776 shares for an estimated $3,309,124
- DANA AFTAB (EVP, Research and Development) sold 48,383 shares for an estimated $2,056,277
- PATRICK J. HALEY (EVP, Commercial) sold 34,387 shares for an estimated $1,515,091
- MARY C BECKERLE has made 0 purchases and 2 sales selling 24,622 shares for an estimated $1,032,413.
- GEORGE POSTE sold 20,634 shares for an estimated $948,957
- SUE GAIL ECKHARDT has made 0 purchases and 2 sales selling 18,838 shares for an estimated $805,139.
- JACK L WYSZOMIERSKI sold 7,535 shares for an estimated $324,683
- TOMAS J. HEYMAN sold 4,544 shares for an estimated $201,253
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EXEL Hedge Fund Activity
We have seen 315 institutional investors add shares of $EXEL stock to their portfolio, and 329 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FARALLON CAPITAL MANAGEMENT LLC removed 6,498,000 shares (-28.8%) from their portfolio in Q2 2025, for an estimated $286,399,350
- ASSETMARK, INC added 2,955,813 shares (+1230.8%) to their portfolio in Q3 2025, for an estimated $122,075,076
- TWO SIGMA ADVISERS, LP removed 1,856,300 shares (-81.2%) from their portfolio in Q2 2025, for an estimated $81,816,422
- QUBE RESEARCH & TECHNOLOGIES LTD added 1,665,110 shares (+120.5%) to their portfolio in Q2 2025, for an estimated $73,389,723
- ALLIANZ ASSET MANAGEMENT GMBH added 1,490,520 shares (+153.3%) to their portfolio in Q3 2025, for an estimated $61,558,475
- VANGUARD GROUP INC removed 1,404,523 shares (-5.1%) from their portfolio in Q3 2025, for an estimated $58,006,799
- UBS GROUP AG added 1,328,087 shares (+100.1%) to their portfolio in Q3 2025, for an estimated $54,849,993
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EXEL Analyst Ratings
Wall Street analysts have issued reports on $EXEL in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 11/05/2025
- Leerink Partners issued a "Outperform" rating on 10/21/2025
- Morgan Stanley issued a "Overweight" rating on 10/21/2025
- Goldman Sachs issued a "Buy" rating on 09/17/2025
- HC Wainwright & Co. issued a "Buy" rating on 08/12/2025
- JMP Securities issued a "Market Outperform" rating on 07/29/2025
- Truist Securities issued a "Buy" rating on 07/29/2025
To track analyst ratings and price targets for $EXEL, check out Quiver Quantitative's $EXEL forecast page.
$EXEL Price Targets
Multiple analysts have issued price targets for $EXEL recently. We have seen 17 analysts offer price targets for $EXEL in the last 6 months, with a median target of $46.0.
Here are some recent targets:
- Ashwani Verma from UBS set a target price of $40.0 on 11/06/2025
- Yaron Werber from TD Cowen set a target price of $51.0 on 11/05/2025
- Etzer Darout from Barclays set a target price of $41.0 on 11/05/2025
- Robert Burns from HC Wainwright & Co. set a target price of $49.0 on 11/05/2025
- Sean Laaman from Morgan Stanley set a target price of $45.0 on 11/05/2025
- Leonid Timashev from RBC Capital set a target price of $45.0 on 10/21/2025
- Christopher Liu from Leerink Partners set a target price of $48.0 on 10/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
